Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Cerullo

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Molecular Sciences|April 3, 2021
Oncolytic Adenoviruses for Cancer TherapyLorella Tripodi, Maria Vitale, Vincenzo Cerullo, et al.
Cancers|June 27, 2020
Uncovering the Tumor Antigen Landscape: What to Know about the Discovery ProcessSara Feola, Jacopo Chiaro, Beatriz Martins, et al.
Advances in Cancer Research|October 2, 2012
Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humansVincenzo Cerullo, Anniina Koski, Markus Vähä-Koskela, et al.
Current Cancer Drug Targets|May 4, 2017
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune SystemVincenzo Cerullo, Cristian Capasso, Markus Vaha-Koskela, et al.
Cancer Research|March 10, 2021
Patient-Derived Organoids for Precision Cancer ImmunotherapyMikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2002
Generation of helper-dependent adenoviral vectors by homologous recombinationGabriele Toietta, Lucio Pastore, Vincenzo Cerullo, et al.
Journal for Immunotherapy of Cancer|July 12, 2019
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor siteAlessandra Lopes, Sara Feola, Sophie Ligot, et al.
Current Pharmaceutical Biotechnology|July 12, 2011
Oncolytic viruses for induction of anti-tumor immunityAlex W Tong, Neil Senzer, Vincenzo Cerullo, et al.
Bioconjugate Chemistry|January 9, 2019
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer TherapyAndrea Patrizia Falanga, Vincenzo Cerullo, Maria Marzano, et al.
Human Gene Therapy|May 13, 2011
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivoMasataka Suzuki, Racel Cela, Terry K Bertin, et al.
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|April 3, 2021
Oncolytic Adenoviruses for Cancer TherapyLorella Tripodi, Maria Vitale, Vincenzo Cerullo, et al.
Cancers|June 27, 2020
Uncovering the Tumor Antigen Landscape: What to Know about the Discovery ProcessSara Feola, Jacopo Chiaro, Beatriz Martins, et al.
Advances in Cancer Research|October 2, 2012
Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humansVincenzo Cerullo, Anniina Koski, Markus Vähä-Koskela, et al.
Current Cancer Drug Targets|May 4, 2017
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune SystemVincenzo Cerullo, Cristian Capasso, Markus Vaha-Koskela, et al.
Cancer Research|March 10, 2021
Patient-Derived Organoids for Precision Cancer ImmunotherapyMikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2002
Generation of helper-dependent adenoviral vectors by homologous recombinationGabriele Toietta, Lucio Pastore, Vincenzo Cerullo, et al.
Journal for Immunotherapy of Cancer|July 12, 2019
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor siteAlessandra Lopes, Sara Feola, Sophie Ligot, et al.
Current Pharmaceutical Biotechnology|July 12, 2011
Oncolytic viruses for induction of anti-tumor immunityAlex W Tong, Neil Senzer, Vincenzo Cerullo, et al.
Bioconjugate Chemistry|January 9, 2019
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer TherapyAndrea Patrizia Falanga, Vincenzo Cerullo, Maria Marzano, et al.
Human Gene Therapy|May 13, 2011
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivoMasataka Suzuki, Racel Cela, Terry K Bertin, et al.
Pageof 14